DIACOMIT is the only FDA-approved antiseizure medication specifically for seizures associated with Dravet syndrome in children as young as 6 months. It is indicated for patients weighing 15 pounds or more and taking clobazam.
Save a copy of the Medication Guide.
You can also hover on the image below and use the menu to navigate through the document on your browser.
WARNINGS & PRECAUTIONS
SleepinessDIACOMIT can cause sleepiness. Your healthcare provider should monitor you for sleepiness, particularly when DIACOMIT is used with other depressants or clobazam.
Decreased Appetite and WeightDIACOMIT can cause a loss in appetite and weight. Your healthcare provider should monitor your growth and weight carefully.
DIACOMIT (stiripentol) is now approved for children with Dravet as young as 6 months.* You can make the DIACOMITment sooner!
Review Prescribing Info
*15 lb or more and taking clobazam